MedTrace Logo

Brain Image Markers Associated With Cognitive Training and Aerobic Exercise in Schizophrenia

NCT03509597 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-07-30

No results posted yet for this study

Summary

This study evaluates the brain correlates of Cognitive Training and Aerobic Exercise in schizophrenia. A third of participants will receive Cognitive Training plus Standard Care for schizophrenia. Another third of participants will receive Aerobic Exercise Training plus Standard Care for schizophrenia. A control group will of participants will receive Standard Care plus Occupational Activities for the same duration and frequency as the experimental groups.

Conditions

Interventions

BEHAVIORAL

Aerobic Exercise

Physical exercise training consisting of aerobic exercise and strength/resistance training.

BEHAVIORAL

Cognitive Training

Cognitive remediation program using REHACOP rehabilitation program.

BEHAVIORAL

Treatment as usual

Standard care for schizophrenia + Leisure and free time activities.

BEHAVIORAL

Occupational Activities

Engagement in activities aimed to keep patients actively involved in demanding tasks.

Sponsors & Collaborators

  • University of Deusto

    collaborator OTHER

  • University of the Basque Country (UPV/EHU)

    collaborator OTHER

  • Red Salud Mental Araba

    lead OTHER_GOV

Principal Investigators

  • Pedro M Sanchez Gomez, MD · Hospital Psiquiatrico de Alava. Red de Salud Mental de Araba.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2019-12-31
Completion
2020-06-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03509597 on ClinicalTrials.gov